Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Jublia
| Field | Information |
|---|---|
| Medication Name | Jublia |
| Generic Name | Efinaconazole |
| Purpose | Antifungal medication used to treat onychomycosis (fungal infection of the toenails) |
| Mechanism of Action | Inhibits fungal lanosterol 14-alpha demethylase, an enzyme necessary for ergosterol synthesis, thus disrupting fungal cell membrane formation. |
| Dosage Forms | Topical solution |
| Available Strengths | 10% |
| Dosage Frequency | Apply to affected toenail(s) once daily for 48 weeks |
| Common Side Effects | Ingrown toenail, application site reactions (e.g., inflammation, burning, swelling), vesicles, pain |
| Serious Side Effects | Severe allergic reactions (rare) |
| Drug Interactions | No significant drug interactions reported; however, always inform your doctor of all medications you are taking. |
| Important Notes | For topical use on toenails only. Avoid contact with eyes and mucous membranes. Nail should be cleaned and trimmed before application. |
| Storage | Store at room temperature, away from heat and direct light. Keep the bottle tightly closed when not in use. |
| Missed Dose | Apply as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. |
| Alternatives | Ciclopirox, Terbinafine, Itraconazole, Griseofulvin |
Jublia Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Ciclopirox (Penlac) | Inhibits the uptake of precursors for cell membrane synthesis | Topical solution applied to the affected nails. May be less effective than oral antifungals. |
| Terbinafine (Lamisil) | Inhibits squalene epoxidase, a key enzyme in fungal sterol biosynthesis | Oral medication. Requires liver function monitoring. |
| Itraconazole (Sporanox) | Inhibits fungal lanosterol 14-alpha demethylase | Oral medication. Can have drug interactions and requires monitoring. |
| Griseofulvin (Gris-PEG) | Inhibits fungal cell mitosis | Oral medication. Older treatment option with potential side effects and drug interactions. |
Jublia Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Ingrown toenail | Severe allergic reactions (rare) |
| Application site reactions (inflammation, burning, swelling) | Severe blistering, swelling, or oozing at the application site |
Jublia Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Onychomycosis (Toenail Fungus) | Apply topically once daily | Apply topically once daily for 48 weeks | Apply to clean, dry, and trimmed toenails. Ensure entire nail surface is covered. |
Jublia Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $500 |
| Without Insurance (U.S.) | $700 |
| From Canada | $550 |
